Upcoming Medical Conferences in MontpellierSearch Criteria : France Montpellier
Jun 24 - 29, 2019 | EUR €850 | Montpellier, Occitanie
Evidence Based Radiation Oncology is organized by European Society for Radiotherapy and Oncology (ESTRO) and will be held from Jun 24 - 29, 2019 at ICM (Cancer Institute of Montpellier), Montpellier, Occitanie, France. Target Audience: This course is aimed primarily at trainee radiation oncologists. It may also be of interest to medical physicists and technologists who would like an overview of current clinical practice in the major treatment sites. Prerequesties: Before commencing this course participants should: • Review their institution’s radiotherapy treatment protocols in those areas covered by this course and be prepared to apply and discuss these in case discussions • Try to distinguish those areas of their practice that can be justified by the available evidence from those where the evidence-basis is uncertain • Be prepared to ask questions and contribute to discussions. Course Aim: The course focuses on the concept of evidence-based medicine and describes the methodology underlying clinical research. Areas of biomedical statistics necessary for participants to develop skills of critical reading and presentation of research evidence will be covered The course will explore the state-of-the-art of radiation therapy in the major tumour sites: breast,oesophagusand stomach, rectum, prostate, head and neck, lung, CNS and gynaecological malignancies. A separate session will deal with the major issues in palliative radiation therapy The clinical component of the course will comprise a combination of lectures and case discussions. Participants will have the opportunity to discuss clinical scenarios in small groups before the management options are then discussed in the light of the research evidence in plenary sessions. Course Content: • General introduction to evidence-based medicine • The terminology of radiation therapy, errors and uncertainties in daily practice • Statistics for the radiation oncologist, how to describe and interpret data from clinical trials and meta-analyses • Prostate cancer • Lung cancer • Rectal cancer • Head and neck cancer • CNS malignancies • Gynaecological malignancies • Breast cancer • Gastric and oesophageal cancer • Radiation therapy in palliative care. Objectives: • Define the hierarchy of evidence and use this to evaluate the basis of radiation treatment protocols • Identify areas of uncertainty in daily radiotherapy practice • Describe the statistical basis for the design of clinical trials and critically appraise the published literature • Identify those aspects of current radiotherapy practice which are supported by the highest levels of evidence and those which are not • Outline the evidence supporting the use of altered fractionation regimens and combined-modality treatment • Critically evaluate an oral or written scientific presentation. Additional details will be posted as soon as they are available.